Biocryst Pharmaceuticals reported $2.01B in Market Capitalization this July of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Alnylam Pharmaceuticals ALNY:US $ 19.71B 0.57B
Biocryst Pharmaceuticals BCRX:US $ 3B 0.51B
Chemocentryx CCXI:US $ 1.78B 0.78B
Chugai Pharma 4519:JP 6879.1B 607.82B
Daiichi Sankyo 4568:JP 5218.05B 477.02B
Dbv Technologies DBVT:US 0.18B 0.01B
Enanta Pharmaceuticals ENTA:US $ 1.46B 0.06B
Gilead Sciences GILD:US $ 74.66B 16.42B
GlaxoSmithKline GSK:LN 83.74B 2.9B
Glaxosmithkline GSK:US 109.98B 0.61B
Intra Cellular Therapies ITCI:US $ 5.75B 1.49B
IONIS PHARMACEUT IONS:US $ 5.25B 0.95B
Karyopharm Therapeutics KPTI:US $ 0.58B 0.1B
Mirati Therapeutics MRTX:US $ 4.56B 3.54B
Neurocrine Biosciences NBIX:US $ 8.95B 0.87B
Novavax NVAX:US $ 5.62B 5.2B
Ptc Therapeutics PTCT:US $ 2.66B 0.15B
Regeneron Pharmaceuticals REGN:US $ 75.81B 7.89B
Roche Holding ROG:VX 300.5B 1.25B
Sarepta Therapeutics SRPT:US $ 6.81B 1.03B
Ultragenyx Pharmaceutical RARE:US $ 5.04B 0.69B
Vertex Pharmaceuticals VRTX:US $ 66.69B 10.85B
YTE INCY:US $ 17.58B 1.36B